Ministry of National Health Services, Regulations and Coordination

Drug Regulatory Authority of Pakistan

National Control Laboratory for Biologicals

Home Up DBER About Us Contents FAQs WHO LINKS

Tetanus Toxoid

NCLB implements Lot release and Lab testing of Biological Drugs as per Schedule I of DRAP Act, 2012 (Act No. XXI of 2012)

and is part of DRAP Authority under Section 3 of this Act.

2021 is 21st year of service of NCLB


inside nclb left wing nclb enterance inside nclb right wing


Manufactured by NIH Islamabad, and AVP Islamabad WHO TRS
Both manufacturers use concentrate from same manufacturer; the imported concentrate is diluted adsorbed on aluminium base adjuvant and filled in either multidose vials or single dose ampoules. Recommendations for Diphtheria, Tetanus, Pertussis and Combined Vaccines, Amendments 2003
WHO Technical Report Series, No. 927, Annex 5
Both manufacturers work in GMP compliant facilities and test the vaccine according to WHO recommendations. Requirements for Diphtheria, Tetanus, Pertussis and Combined Vaccines
WHO Technical Report Series 800, 1990
List of Products presently under going Lot Release Performance of NCLB Lot Release system from 2007 onwards  

Home ] Up ]

Send mail to with questions or comments about this web site.
Copyright 2011 National Control Laboratory for Biologicals
Last modified: 13-Jul-2021